Literature DB >> 2720653

Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.

L A Smets1, C Loesberg, M Janssen, E A Metwally, R Huiskamp.   

Abstract

Radio-iodinated m-iodobenzylguanidine (MIBG), an analogue of the neurotransmitter norepinephrine (NE), is increasingly used in the diagnosis and treatment of neural crest tumors. Active uptake and subsequent retention of MIBG and NE was studied in human neuroblastoma SK-N-SH cells. Neuron-specific uptake of [125I]MIBG and [3H]NE saturated at extracellular concentration of 10(-6) M and exceeded by 20-30-fold that by passive diffusion alone. A minimum of 50% of accumulated MIBG remained permanently stored but the SK-N-SH cells were incapable of retaining recaptured [3H]NE. [125I]MIBG was displaced from intracellular binding sites by unlabeled MIBG with 10-fold higher potency than by unlabeled NE. MIBG stored in SK-N-SH cells was insensitive to depletion by the inhibitor of granular uptake reserpine (RSP) and was not precipitated in a granular fraction by differential centrifugation. Only few electron-dense granules were found in these cells by electron microscopy. In contrast, MIBG storage in PC-12 pheochromocytoma cells which contained many storage granules, was sensitive to RSP and part of accumulated drug was recovered in a granular fraction. Accordingly, storage of MIBG in the SK-N-SH neuroblastoma cells is predominantly extravesicular and thus essentially different from that of biogenic amines in normal adrenomedullary tissue or in pheochromocytoma tumors, while sharing with these tissues a common mechanism of active uptake.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2720653

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles.

Authors:  Prashant Mandela; Michelle Chandley; Yao-Yu Xu; Meng-Yang Zhu; Gregory A Ordway
Journal:  Neurochem Int       Date:  2010-02-20       Impact factor: 3.921

Review 2.  Targeted radiotherapy for neuroblastoma.

Authors:  S Meller
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

3.  Guidelines on nuclear medicine imaging in neuroblastoma.

Authors:  Zvi Bar-Sever; Lorenzo Biassoni; Barry Shulkin; Grace Kong; Michael S Hofman; Egesta Lopci; Irina Manea; Jacek Koziorowski; Rita Castellani; Ariane Boubaker; Bieke Lambert; Thomas Pfluger; Helen Nadel; Susan Sharp; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10       Impact factor: 9.236

4.  Direct Involvement of Androgen Receptor in Oxytocin Gene Expression: Possible Relevance for Mood Disorders.

Authors:  Dan Dai; Qiao-Chu Li; Qiong-Bin Zhu; Shao-Hua Hu; Rawien Balesar; Dick Swaab; Ai-Min Bao
Journal:  Neuropsychopharmacology       Date:  2017-04-27       Impact factor: 7.853

Review 5.  Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.

Authors:  A R Wafelman; C A Hoefnagel; R A Maes; J H Beijnen
Journal:  Eur J Nucl Med       Date:  1994-06

6.  A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma.

Authors:  K Osmanagaoglu; M Lippens; Y Benoit; E Obrie; K Schelstraete; M Simons
Journal:  Eur J Nucl Med       Date:  1993-12

7.  Ascorbic-acid-mediated iron release from cellular ferritin and its relation to the formation of DNA strand breaks in neuroblastoma cells.

Authors:  S L Baader; G Bruchelt; T C Carmine; H N Lode; A G Rieth; D Niethammer
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 8.  Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.

Authors:  Steven G DuBois; Katherine K Matthay
Journal:  Nucl Med Biol       Date:  2008-08       Impact factor: 2.408

9.  Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.

Authors:  William Temple; Lori Mendelsohn; Grace E Kim; Erin Nekritz; W Clay Gustafson; Lawrence Lin; Kathy Giacomini; Arlene Naranjo; Collin Van Ryn; Gregory A Yanik; Susan G Kreissman; Michael Hogarty; Katherine K Matthay; Steven G DuBois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

10.  A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.

Authors:  Ganesan Vaidyanathan; Philip C Welsh; Katia C Vitorello; Stacey Snyder; Henry S Friedman; Michael R Zalutsky
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-16       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.